Trial Profile
Multicentre, Placebo-Controlled, Multi-Dosis, Phase I Clinical Trial to Evaluate the Tolerability and Bioavailability of TGF β1 Inhibitor Peptide 144 After Topical Administration in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Disitertide (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions
- Sponsors Isdin
- 13 May 2014 New trial record